Based on these results, they concluded that HIF-1 signaling worsens the metabolic profile, accelerates the progression of NAFLD, and exacerbates liver fibrosis [48]. This evidence concerns the gene HIF1A and metabolic dysfunction-associated steatotic liver disease.